Bridgeway Capital Management’s Sunshine Biopharma SBFM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1
Closed -$17.3K – 1335
2024
Q1
$17.3K Hold
1
– – ﹤0.01% 1294
2023
Q4
$77.7K Hold
1
– – ﹤0.01% 1277
2023
Q3
$89K Hold
1
– – ﹤0.01% 1247
2023
Q2
$141K Hold
1
– – ﹤0.01% 1202
2023
Q1
$200K Hold
1
– – 0.01% 1105
2022
Q4
$183K Hold
1
– – ﹤0.01% 1104
2022
Q3
$221K Hold
1
– – 0.01% 1120
2022
Q2
$614K Buy
+1
New +$977K 0.01% 835

Other funds holding SBFM

Bridgeway Capital Management's SBFM Position: Q2 2024 in Review

Bridgeway Capital Management sold out of Sunshine Biopharma (SBFM) in Q2 2024, closing a stake of 1 share — an estimated $17.3K sold.

Bridgeway Capital Management first reported a position in SBFM in Q2 2022 and held it in 8 quarters. The position peaked at $614K in Q2 2022. 5 funds tracked by Wall St. Rank hold SBFM as of Q2 2024.

  • Bridgeway Capital Management reported no remaining Sunshine Biopharma position as of Q2 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 1 Sunshine Biopharma share in Q2 2024, an estimated $17.3K.
  • Bridgeway Capital Management first reported a position in Sunshine Biopharma in Q2 2022 and held it in 8 quarters.
  • Bridgeway Capital Management's Sunshine Biopharma position peaked at $614K in Q2 2022.
  • 5 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2024.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.